Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke

OBJECTIVE: Delayed thrombolytic therapy with recombinant tissue plasminogen activator (tPA) may exacerbate blood‐brain barrier (BBB) breakdown after ischemic stroke and lead to catastrophic hemorrhagic transformation (HT). Rosiglitazone(RSG), a widely used antidiabetic drug that activates peroxisome...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:CNS Neurosci Ther
Autori principali: Li, Yan, Zhu, Zi‐Yu, Lu, Bing‐Wei, Huang, Ting‐Ting, Zhang, Yue‐Man, Zhou, Na‐Ying, Xuan, Wei, Chen, Zeng‐Ai, Wen, Da‐Xiang, Yu, Wei‐Feng, Li, Pei‐Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6887660/
https://ncbi.nlm.nih.gov/pubmed/31756041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13260
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi